Chronic graft rejection.

[1]  T. Paavonen,et al.  Chronic Allograft Rejection , 1993 .

[2]  U. Heemann,et al.  Transplantation immunology: an introduction. , 1994, Transplant immunology.

[3]  U. Heemann,et al.  Cytokines and adhesion molecules in chronic rejection. , 1994, Clinical transplantation.

[4]  I. Yokoyama,et al.  Effect of Carolina rinse solution in cultured rat sinusoidal endothelial cells. , 1993, Transplantation proceedings.

[5]  M. Corsi,et al.  Improved grafted rat heart metabolic function using defibrotide. , 1993, Transplantation proceedings.

[6]  L. Toledo-Pereyra,et al.  Effect of adenosine and allopurinol on liver ischemia-reperfusion. , 1993, Transplantation proceedings.

[7]  T. Nagao,et al.  Warm renal ischemia and reperfusion injury in rats treated with cyclophosphamide and/or granulocyte colony-stimulating factor. , 1993, Transplantation proceedings.

[8]  R. Margreiter,et al.  Which organ preservation solution best protects vascular endothelium? , 1993, Transplantation proceedings.

[9]  B. Trimarco,et al.  Influence of hypercholesterolemia on adrenal steroid metabolism and electrolyte balance in spontaneously hypertensive rats. , 1993, Endocrinology.

[10]  J. Crawford,et al.  Evaluation of University of Wisconsin cold-storage solution in warm hypoxic perfusion of rat liver: the addition of fructose reduces injury. , 1993, Gastroenterology.

[11]  E. Gröne,et al.  Role of lipoproteins in progressive renal disease. , 1993, American journal of hypertension.

[12]  S. Yilmaz,et al.  The impact of acute episodes of rejection on the generation of chronic rejection in rat renal allografts. , 1993, Transplantation.

[13]  M. Miyasaka,et al.  ICAM-1 and LFA-1/CD18 expression in chronic renal allograft rejection. , 1993, Transplantation proceedings.

[14]  Y. Nakajima,et al.  Protective effect of the calcium channel blocker diltiazem on hepatic function following warm ischemia. , 1993, Journal of Surgical Research.

[15]  L. Ferrell,et al.  Reversal of chronic rejection after treatment failure with FK506 and RS61443. , 1993, Transplantation.

[16]  W. Baldwin,et al.  CYTOKINES, ADHESION MOLECULES, AND THE PATHOGENESIS OF CHRONIC REJECTION OF RAT RENAL ALLOGRAFTS , 1993, Transplantation.

[17]  D. Adams,et al.  Chronic Rejection in Experimental Cardiac Transplantation: Studies in the Lewis‐F344 Model , 1993, Immunological reviews.

[18]  B. Meiser,et al.  Graft Vessel Disease: The Impact of Immunosuppression and Possible Treatment Strategies , 1993, Immunological reviews.

[19]  C. Ewel,et al.  Chronic Graft Rejection: Accelerated Transplant Arteriosclerosis , 1993, Immunological reviews.

[20]  B. Fellström,et al.  Pathogenesis and Treatment Perspectives of Chronic Graft Rejection (CVR) , 1993, Immunological reviews.

[21]  J F Burdick,et al.  International standardization of criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. , 1993, Kidney international.

[22]  A. Allison,et al.  Mycophenolate mofetil (RS-61443): Mechanisms of action and effects in transplantation , 1993 .

[23]  A. Matas,et al.  The living donor—risks, benefits and related concerns , 1993 .

[24]  A. Davidoff,et al.  GLOMERULAR CAPILLARY PRESSURES IN LONG‐SURVIVING RAT RENAL ALLOGRAFTS , 1993, Transplantation.

[25]  G. Sirchia,et al.  GENOMIC HLA‐DR COMPATIBILITY IN LONG‐TERM SURVIVING RECIPIENTS OF CADAVER KIDNEY TRANSPLANTS , 1993, Transplantation.

[26]  T. Cacciarelli,et al.  Influence of warm ischemia on cyclosporine nephrotoxicity in renal isografts in rats. , 1993, Transplantation proceedings.

[27]  K. Badr,et al.  THE EFFECTS OF SURGERY AND ACUTE REJECTION ON GLOMERULAR HEMODYNAMICS IN THE TRANSPLANTED RAT KIDNEY , 1993, Transplantation.

[28]  Takaaki Kobayashi,et al.  HLA‐DRB1 MATCHING AS A RECIPIENT SELECTION CRITERION IN CADAVERIC RENAL TRANSPLANTATION , 1993, Transplantation.

[29]  J. Neuberger,et al.  Chronic rejection of the liver allograft. , 1993, Gastroenterology clinics of North America.

[30]  B. Brenner,et al.  Nephron underdosing: a programmed cause of chronic renal allograft failure. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  C. Ponticelli,et al.  Hypertension after renal transplantation. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[32]  M. Suthanthiran,et al.  EXCELLENT OUTCOME WITH A CALCIUM CHANNEL BLOCKER—SUPPLEMENTED IMMUNOSUPPRESSIVE REGIMEN IN CADAVERIC RENAL TRANSPLANTATION: A POTENTIAL STRATEGY TO AVOID ANTIBODY INDUCTION PROTOCOLS , 1993, Transplantation.

[33]  G. Klintmalm,et al.  CAUSES OF LATE GRAFT LOSS AFTER LIVER TRANSPLANTATION , 1993, Transplantation.

[34]  D. Dunn,et al.  Early versus late acute renal allograft rejection: impact on chronic rejection. , 1993 .

[35]  R. Ross.  The pathogenesis of atherosclerosis: a perspective for the 1990s , 1993, Nature.

[36]  H. Benediktsson,et al.  Chronic transplant rejection: Magnitude of the problem and pathogenetic mechanisms , 1993 .

[37]  J. Waltenberger,et al.  Impact of ischemia time on chronic vascular rejection in the rat--effects of angiopeptin. , 1993, Transplantation proceedings.

[38]  J. Nilsson.  Lipid oxidation, vascular inflammation, and coronary atherosclerosis. , 1993, Transplantation proceedings.

[39]  C. Heldin,et al.  Possible in vivo effect and clinical utility of platelet-derived growth factor and PDGF antagonists. , 1993, Transplantation proceedings.

[40]  M. Foegh.  Accelerated cardiac transplant atherosclerosis/chronic rejection in rabbits: inhibition by angiopeptin. , 1993, Transplantation proceedings.

[41]  Y. Vanrenterghem,et al.  Use of NSAIDs in kidney transplantation. , 1993, Transplantation proceedings.

[42]  J. Chapman,et al.  Analysis of HLA-DR matching in DNA-typed cadaver kidney transplants. , 1993, Transplantation.

[43]  A. Monaco,et al.  Chronic rejection and suboptimal immunosuppression. , 1993, Transplantation proceedings.

[44]  B. Konieczny,et al.  Chronic rejection of organ allografts may arise from injuries sustained in recurring foci of acute rejection that resolve spontaneously. , 1993, Transplantation proceedings.

[45]  S. Teraoka,et al.  Controlled prospective study of treatment for chronic rejection after kidney transplantation by thromboxane synthetase inhibitor. , 1993, Transplantation proceedings.

[46]  D. Dunn,et al.  Risk factors for chronic rejection in renal allograft recipients. , 1993, Transplantation.

[47]  A. Matas,et al.  Half-life and risk factors for kidney transplant outcome--importance of death with function. , 1993, Transplantation.

[48]  H. Isoniemi,et al.  LONG‐TERM CONSEQUENCES OF DIFFERENT IMMUNOSUPPRESSIVE REGIMENS FOR RENAL ALLOGRAFTS , 1993, Transplantation.

[49]  S. Hunt,et al.  A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. , 1993, The New England journal of medicine.

[50]  J. Barry,et al.  Cytokine-release syndrome: differences between high and low doses of OKT3. , 1993, Transplantation proceedings.

[51]  P. Hämmäinen.  Single lung transplantation in piglets. Technique and follow-up. , 1993, Scandinavian journal of thoracic and cardiovascular surgery.

[52]  A. Górski,et al.  Low dose heparin: efficacious treatment for chronic renal allograft rejection. , 1993, Archivum immunologiae et therapiae experimentalis.

[53]  B. Brenner,et al.  Glomerular hypertension: cause and consequence of renal injury. , 1992, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.